Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,964 | 170 | 93.8% |
| Education | $261.93 | 3 | 6.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Secura Bio, Inc. | $699.62 | 8 | $0 (2023) |
| PFIZER INC. | $285.35 | 15 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $247.55 | 13 | $0 (2024) |
| Daiichi Sankyo Inc. | $208.42 | 11 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $185.27 | 11 | $0 (2024) |
| Genentech USA, Inc. | $184.56 | 9 | $0 (2024) |
| Seagen Inc. | $178.02 | 3 | $0 (2023) |
| Celgene Corporation | $172.68 | 10 | $0 (2024) |
| Eisai Inc. | $165.97 | 7 | $0 (2024) |
| Janssen Biotech, Inc. | $154.82 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,354 | 117 | PFIZER INC. ($237.10) |
| 2023 | $1,149 | 47 | Secura Bio, Inc. ($240.32) |
| 2022 | $604.60 | 7 | Secura Bio, Inc. ($459.30) |
| 2021 | $117.24 | 2 | Epizyme, Inc., ($99.95) |
All Payment Transactions
173 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Spectrum Pharmaceuticals Inc. | ROLVEDON (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Oncology | ||||||
| 12/19/2024 | Pharmacosmos Therapeutics Inc. | COSELA (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: HEMATOLOGY | ||||||
| 12/17/2024 | ABBVIE INC. | EPKINLY (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: ONCOLOGY | ||||||
| 12/16/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $27.18 | General |
| Category: ONCOLOGY | ||||||
| 12/10/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.99 | General |
| 11/27/2024 | Cumberland Pharmaceuticals, Inc. | SANCUSO (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: ONCOLOGY | ||||||
| 11/26/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | Cash or cash equivalent | $122.80 | General |
| 11/25/2024 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | Cash or cash equivalent | $18.45 | General |
| Category: ONCOLOGY | ||||||
| 11/22/2024 | RECORDATI_RARE_DISEASES_INC. | SYLVANT (Drug) | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: ONCOLOGIC AGENT | ||||||
| 11/20/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2024 | Genentech USA, Inc. | Itovebi (Biological) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: BioOncology | ||||||
| 11/18/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $17.00 | General |
| Category: Hematology | ||||||
| 11/15/2024 | TAIHO ONCOLOGY, INC. | LONSURF (Drug), INQOVI | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: Oncology | ||||||
| 11/14/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Oncology | ||||||
| 11/11/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Oncology | ||||||
| 11/08/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $23.77 | General |
| Category: Oncology / Rare Diseases | ||||||
| 11/07/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Oncology | ||||||
| 11/05/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: ONCOLOGY | ||||||
| 11/05/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Iron Deficiency Anemia | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $11.68 | General |
| Category: Oncology | ||||||
| 11/01/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug), Somatuline Depot | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: Oncology | ||||||
| 10/29/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $28.45 | General |
| Category: Iron Deficiency Anemia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 34 | 59 | $21,605 | $8,271 |
All Medicare Procedures & Services
3 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 31 | $8,525 | $4,161 | 48.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 16 | $7,200 | $2,124 | 29.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $5,880 | $1,986 | 33.8% |
About Cody Milliman
Cody Milliman is a Medical Oncology healthcare provider based in Baton Rouge, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/10/2017. The National Provider Identifier (NPI) number assigned to this provider is 1730615980.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Cody Milliman has received a total of $4,226 in payments from pharmaceutical and medical device companies, with $2,354 received in 2024. These payments were reported across 173 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($3,964).
As a Medicare-enrolled provider, Milliman has provided services to 34 Medicare beneficiaries, totaling 59 services with total Medicare billing of $8,271. Data is available for 1 year (2023–2023), covering 3 distinct procedure/service records.
Practice Information
- Specialty Medical Oncology
- Location Baton Rouge, LA
- Active Since 05/10/2017
- Last Updated 09/20/2023
- Taxonomy Code 207RX0202X
- Entity Type Individual
- NPI Number 1730615980
Products in Payments
- COPIKTRA (Drug) $699.62
- IBRANCE (Drug) $217.03
- REBLOZYL (Biological) $172.68
- Lenvima (Drug) $165.97
- Enhertu (Drug) $141.62
- KEYTRUDA (Biological) $132.37
- IMFINZI (Biological) $121.62
- TAZVERIK (Drug) $99.95
- Columvi (Biological) $73.13
- BRUKINSA (Drug) $72.29
- SYLVANT (Drug) $71.46
- TECVAYLI (Biological) $69.12
- INJECTAFER (Drug) $66.80
- LIBTAYO (Biological) $66.25
- OGSIVEO (Drug) $65.62
- PLUVICTO (Drug) $63.94
- MONOFERRIC (Drug) $60.32
- DARZALEX (Biological) $60.13
- EPKINLY (Drug) $58.92
- Orserdu (Drug) $58.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Oncology Doctors in Baton Rouge
Dr. Michael Castine, Md, MD
Medical Oncology — Payments: $332,086
Dr. Christopher Mccanless, Md, MD
Medical Oncology — Payments: $23,744
Lauren Juneja, Md, MD
Medical Oncology — Payments: $13,511
Mr. William Varnado
Medical Oncology — Payments: $4,103